Internship

Co-op Recombinant Mammalian MSAT

Ast

Posted on 10/25/2024

Sanofi

Sanofi

10,001+ employees

Global healthcare provider of medicines and vaccines

Biotechnology
Healthcare

No H1B Sponsorship

Framingham, MA, USA

Must be able to relocate to Framingham, MA and work 40 hours/week, Monday-Friday.

Category
Biology Lab & Research
Biology & Biotech
Required Skills
PowerPoint/Keynote/Slides
Requirements
  • Currently pursuing a Bachelor's or Master's degree in Biology, Biological/Biomedical Engineering, Biotechnology, Biochemistry, Chemistry or related field at an accredited college or university with the expectation that you will complete your current degree by the Spring of 2027
  • Must be enrolled in school the semester following your co-op with Sanofi.
  • Must be able to relocate to the office location and work 40hrs/week, Monday-Friday, for the full duration of the co-op
  • Must have permanent US work authorization
  • Basic understanding of general concepts of biochemistry and laboratory procedures
  • Ability to work in Biosafety Level 1 environments and follow lab safety procedures
  • Proficiency in Microsoft Office software (excel, PowerPoint, word).
  • Excellent communication skills, written and verbal; able to effectively communicate with supervisor and team members
  • Highly organized with a keen attention to details
Responsibilities
  • Work on an MSAT development project
  • Evaluate and establish automation on Hamilton
  • Establish semi-automation methods for U/HPLCs
  • Establish sample preparation on the Hamilton.
  • Establish sample normalization, and sample clean-up for already established methods.
  • Establish Robustness and Reproducibility
  • Investigate Sample Vial vs Plate capabilities.
  • Collaborate with the MSAT project team; attend regular team meetings and share study progress and results.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi differentiates itself from competitors by its strong commitment to scientific innovation and a diverse product portfolio that includes prescription medicines and vaccines. Its goal is to enhance health outcomes and improve the quality of life for people globally by delivering effective and safe healthcare solutions.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tolebrutinib's FDA Breakthrough Therapy designation boosts Sanofi's neurology portfolio.
  • Dupixent's EU approval for young children expands Sanofi's pediatric market.
  • Sanofi's partnership with BrightInsight accelerates digital health solution development.

What critics are saying

  • Liver enzyme elevations in tolebrutinib patients may affect market acceptance.
  • Increased competition in rare diseases from biotech startups challenges Sanofi.
  • Regulatory delays could impact Dupixent's approval for chronic spontaneous urticaria.

What makes Sanofi unique

  • Sanofi's Care4Rare program supports innovative solutions for rare diseases.
  • The MyWay app enhances patient engagement and medication adherence.
  • Sanofi's Muse AI tool optimizes patient recruitment in clinical trials.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE